drugset / Trial / NCT05253755
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
Phase 2
Terminated
10 enrolled
DermBiont, Inc.
Clear Dermatology · collabDerm Research, PLLC · collabNorthsoundderm · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis
Timeline
- Start
- 2021-10-06
- Primary completion
- 2022-09-09
- Completion
- 2022-09-09
Outcome
Outcome not reported
Stopped: “Sponsor suspension and not due to safety or site-related matters.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DBI-001 | Unknown | — | Topical |